EXTRAPULMONARY NEUROENDOCRINE CARCINOMA

Clinical trials for EXTRAPULMONARY NEUROENDOCRINE CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new EXTRAPULMONARY NEUROENDOCRINE CARCINOMA trials appear

Sign up with your email to follow new studies for EXTRAPULMONARY NEUROENDOCRINE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Double attack on deadly cancer: new trial aims to control aggressive tumors

Disease control Not yet recruiting

This study is testing whether combining two newer cancer drugs can help control aggressive small cell lung cancer and similar neuroendocrine cancers that have returned or stopped responding to standard treatments. The trial will enroll about 120 adults whose cancer has progressed…

Matched conditions: EXTRAPULMONARY NEUROENDOCRINE CARCINOMA

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

EXTRAPULMONARY NEUROENDOCRINE CARCINOMA

Get alerted when new EXTRAPULMONARY NEUROENDOCRINE CARCINOMA trials appear

Double attack on deadly cancer: new trial aims to control aggressive tumors